Company intelligence / Profile preview
Vividion Therapeutics
San Diego, California, United Statesvividion.com ↗
- Ownership
- Private
- Employees
- ~250
- Development stage
- Preclinical
01
Overview
Vividion Therapeutics has advanced multiple novel small molecule drug candidates into clinical trials using its proprietary chemoproteomic platform. The company has demonstrated the ability to discover covalent allosteric inhibitors for challenging targets such as WRN helicase, with at least one program progressing rapidly into the clinic. Its pipeline includes highly selective therapeutics targeting previously inaccessible disease-causing proteins in oncology and immunology. The breadth of its pipeline spans several programs at various stages of development, though specific late-stage results are not detailed in public sources.[1][8]
- Therapeutic areas
- OncologyImmunologyNeurology
- Modalities
- Small molecules (covalent and allosteric inhibitors)[1][3][8]
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
Roche – collaboration on WRN inhibitor program[8]Celgene – $101M partnership focused on ubiquitin proteasome system-related drug discovery across oncology, inflammatory, neurodegenerative diseases[10]
Beyond the preview
Go deeper on Vividion Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vividion Therapeutics.